Exploration of Lymph Node Metastasis and Tumor Deposit in the Posterior Gastric Mesentery for Distal Gastric Cancer

ConditionGastric Carcinoma

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18-85

SponsorJichao Qin

About this trial

This study aims to evaluate lymph node metastasis and tumor deposit in the posterior gastric mesentery following distal gastrectomy with D2 lymphadenectomy plus complete mesogastric excision (CME) in gastric cancer.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Aged older than 18 years and younger than 85 years

Primary gastric adenocarcinoma confirmed by preoperative pathology result

cT2-4N0-3M0 at preoperative evaluation according to the American Joint 8 Committee on Cancer (AJCC) Cancer Staging Manual 7th Edition

Patients who received distal gastrectomy with D2 lymphadenectomy plus complete mesogastric excision

Disqualifiers

Negative preoperative biopsy

Too late tumour stage or metastasis (cT4b/M1)

BMI>30 kg/m2

Total gastrectomy or proximal gastrectomy

Trial population

Patients who met the above inclusion and exclusion criteria

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

distal gastrectomy with D2 lymphadenectomy plus complete mesogastric excision (CME) in gastric cancer
Procedure/Surgery
distal gastrectomy with D2 lymphadenectomy plus complete mesogastric excision (CME) in gastric cancer

Treatment groups

200 Participants

are divided into 1 treatment group

Group A: Radical gastrectomy with membrane dissection1 intervention

Trial outcomes

Primary outcomes

Rate of lymph node metastasis and tumor deposit in the posterior gastric mesentery

Time frame

through study completion, an average of 1 year

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Jichao Qin

Lead sponsor

First Affiliated Hospital of Zhejiang University

Sponsor institution

Source ClinicalTrials.gov

Apply now